在儿科瘤学患者的心脏移植
Molly K Marshall1, Drishti Tolani2, Jonathan D Bender3,4
1Division of Pediatric Cardiology, Icahn School of Medicine at Mount Sinai Mount Sinai Kravis Children's Hospital, New York, NY.
JHLT open
|March 11, 2026
概括
由于癌症治疗相关的心脏功能障碍 (CTRCD) 导致心力衰竭的儿童癌症幸存者可能受益于心脏移植. 这种程序为非癌症患者提供了可比的生存率,需要谨慎管理.
科学领域:
- 心脏病学 心脏病学
- 儿科瘤学 儿科瘤学
- 心肌病是一种心肌病.
背景情况:
- 儿童癌症的生存率有所改善,儿童癌症幸存者的数量增加 (CCS).
- CCS面临晚期心脏并发症的风险,包括与癌症治疗相关的心脏功能障碍 (CTRCD),可能导致末期心力衰竭.
- 无论是传统的 (环素,辐射) 还是新的癌症疗法,都会带来心脏毒性风险.
研究的目的:
- 审查心脏移植在晚期心力衰竭的CCS中的作用.
- 讨论在CCS中心脏移植患者的选择,临床结果和管理考虑.
- 突出心脏移植的潜力,作为选择性心脏病的可行治疗选择.
主要方法:
- 文献综述专注于心脏移植在CCS与CTRCD.
- 对患者选择标准和临床结果的分析.
- 检查CCS移植后的独特管理挑战和策略.
主要成果:
- 心脏移植是一种可行的治疗选择心脏衰竭与终端阶段的心脏衰竭.
- 目前的数据显示,与非瘤患者相比,CCS患者的移植后生存率相似.
- 癌症综合症带来了独特的挑战,包括免疫抑制,感染和二次癌症风险.
结论:
- 心脏移植可以成为耐心心力衰竭的CCS的有效治疗方法.
- 多学科合作对于有关机械支和移植的决策至关重要.
- 量身定制的免疫抑制和警的长期监测对于优化这一群体的结果至关重要.
相关概念视频
01:28Kidney Transplant I: Introduction
637
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
637
01:22Bone Marrow Sampling and Transplants
2.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K